Multiple Dimensions Support of Medical Device Innovation
Zhao Yixin said, with the increasing national support and speeding up of the globalization process, medical device industry has become one of the most active and rapidly developed industries in China. However, the current medical device
innovation in China has many problems to be solved, such as lack of
multi-agent collaborative innovation cooperative mechanism, loss of part
industrial chain, short of power on core technical R&D, fund and
machinability, differences across provinces for supporting innovative
enterprises, difficulty for innovative product to access to market with
high quality and high price, enterprises difficulty in getting development space through instant market return.
To this end, representative Zhao Yixin suggested: 1. Making supervision on the progress and condition of local governments’ implementation of central government requirement; 2. Specifying the unified local management departments and approaches; 3. Making and implementing policies encouraging innovative technologies and products to be listed in NDRC and NDRL; 4. Protecting appropriate profit of innovative technology and products and stimulating enterprises’ innovation enthusiasm and ability; 5. Simplifying and canceling multiple organizations’ invitation for bid, releasing the market, and letting industrial association, hospitals, doctors selecting new technology and products based on the demand of technical and clinical treatment.
“To promote the medical device innovation in China, CFDA has issued ‘special procedure for review and approval of innovative medical devices’. MOST has also issued the ‘thirteenth Five-year Plan’ in medical device industry. Supporting policies are expected to be
issued after implementation of special project to further detail the
supporting works; an industrial vertical supporting way is expected to
identify funded technology and avoid blind funding; corresponding
policies and regulations on price, bid inviting and hospital entering
are expected to be formulated by NDRC and NHFPC to facilitate innovative
medical devices’ occupation of domestic market; and green
channel at market access and application phases to be established for
innovative products.” Zhao Yixin emphasized.
Establishment of High-level Reviewer Team
Zhao suggested the Ministry of Finance, Ministry of Human Resource and Social Security and other related departments to have investigation and provide policy support: 1. Recruit, based on workload, corresponding number of contract staff as market compensation level, creating conditions to introduce various levels of talents in related fields, especially the high-level leading experts to expand and improve reviewer team.2. Join the compensation level of certified personnel and contract staff by breaking certification boundary through government purchasing service, realizing management mode of equal pay for equal work, stabilizing the existing certified reviewer and maintaining the hard core of review tram.